Sumitomo Mitsui Trust Holdings, Inc. Novo Nordisk A S Transaction History

Sumitomo Mitsui Trust Holdings, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$122.71 - $146.91 $599,683 - $717,949	-4,887 Reduced 52.97%	4,339 $619,000
Q1 2024 Apr 19, 2024	SELL	$102.11 - $135.92 $237,405 - $316,014	-2,325 Reduced 20.13%	9,226 $1.18 Million
Q4 2023 Jan 30, 2024	BUY	$87.78 - $105.45 $27,650 - $33,216	315 Added 2.8%	11,551 $1.19 Million
Q3 2023 Oct 30, 2023	BUY	$90.94 - $199.54 $711,605 - $1.56 Million	7,825 Added 229.4%	11,236 $1.02 Million
Q2 2023 Jul 31, 2023	BUY	$155.98 - $172.65 $532,047 - $588,909	3,411 New	3,411 $552,000

1,955

320M

5.49M

7.78M

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $246B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Trust Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Sumitomo Mitsui Trust Holdings, Inc. with notifications on news.